Artigo de peri??dico
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Registro en:
2365-421X
1
7
10.1186/s41181-022-00177-w
0000-0002-0029-7313
Sem Percentil
84.25
Autor
TOYOHARA, JUN
AL-QAHTANI, MOHAMMED
HUANG, YA-YAO
CAZZOLA, EMILIANO
TODDE, SERGIO
FURUMOTO, SHOZO
MIKOLAJCZAK, RENATA
DECRISTOFORO, CLEMENS
GILLINGS, NIC
YANG, MIN
REILLY, RAYMOND
DUATTI, ADRIANO
DENKOVA, ANTONIA
SCHIRRMACHER, RALF
CARLUCCI, GIUSEPPE
SEIMBILLE, YANN
LIU, ZHAOFEI
ELLIS, BEVERLEY
T. CORNELISSEN, BART
KOPKA, KLAUS
BERNARDES, EMERSON
Resumen
Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.